List of Tables
Table 1. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Cardiovascular and Cerebrovascular Disease Treatment Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Cardiovascular and Cerebrovascular Disease Treatment Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Cardiovascular and Cerebrovascular Disease Treatment Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Cardiovascular and Cerebrovascular Disease Treatment Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Cardiovascular and Cerebrovascular Disease Treatment Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bayer Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 84. Novartis Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Merck Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 89. Merck Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. AstraZeneca Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Bristol Myers Squibb Company Company Information
Table 96. Bristol Myers Squibb Company Description and Business Overview
Table 97. Bristol Myers Squibb Company Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bristol Myers Squibb Company Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 99. Bristol Myers Squibb Company Recent Developments/Updates
Table 100. Abbott Company Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Abbott Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 104. Abbott Recent Developments/Updates
Table 105. Sun Pharma Industries Company Information
Table 106. Sun Pharma Industries Description and Business Overview
Table 107. Sun Pharma Industries Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sun Pharma Industries Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 109. Sun Pharma Industries Recent Developments/Updates
Table 110. Gilead Sciences Company Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Gilead Sciences Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 114. Gilead Sciences Recent Developments/Updates
Table 115. Otsuka Holdings Company Information
Table 116. Otsuka Holdings Description and Business Overview
Table 117. Otsuka Holdings Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Otsuka Holdings Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 119. Otsuka Holdings Recent Developments/Updates
Table 120. Takeda Pharmaceutical Company Information
Table 121. Takeda Pharmaceutical Description and Business Overview
Table 122. Takeda Pharmaceutical Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Takeda Pharmaceutical Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 124. Takeda Pharmaceutical Recent Developments/Updates
Table 125. Johnson & Johnson Company Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Johnson & Johnson Cardiovascular and Cerebrovascular Disease Treatment Drugs Product
Table 129. Johnson & Johnson Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Cardiovascular and Cerebrovascular Disease Treatment Drugs Distributors List
Table 133. Cardiovascular and Cerebrovascular Disease Treatment Drugs Customers List
Table 134. Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Trends
Table 135. Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Drivers
Table 136. Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Challenges
Table 137. Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cardiovascular and Cerebrovascular Disease Treatment Drugs
Figure 2. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Share by Type: 2025 & 2032
Figure 4. Injectable Medications Product Picture
Figure 5. Oral Medications Product Picture
Figure 6. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Share by Application: 2025 & 2032
Figure 8. Dyslipidemia Treatment
Figure 9. Diabetes Treatment
Figure 10. Coronary Heart Disease Treatment
Figure 11. Thrombosis and Coagulation Disorder Treatment
Figure 12. Others
Figure 13. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales (K Units), 2021–2032
Figure 16. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Cardiovascular and Cerebrovascular Disease Treatment Drugs Report Years Considered
Figure 18. Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Players: Market Share by Revenue in Cardiovascular and Cerebrovascular Disease Treatment Drugs in 2025
Figure 21. Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Cardiovascular and Cerebrovascular Disease Treatment Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Cardiovascular and Cerebrovascular Disease Treatment Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Cardiovascular and Cerebrovascular Disease Treatment Drugs by Type (2021–2032)
Figure 56. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Cardiovascular and Cerebrovascular Disease Treatment Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Cardiovascular and Cerebrovascular Disease Treatment Drugs by Application (2021–2032)
Figure 59. Global Cardiovascular and Cerebrovascular Disease Treatment Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Cardiovascular and Cerebrovascular Disease Treatment Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
